surfac
engin
carbon
nanotub
cnt
attract
recent
attent
scientist
owe
vivid
biomed
pharmaceut
applic
focu
review
highlight
import
role
surfac
engin
cnt
highli
challeng
reward
area
nanotechnolog
major
strength
review
lie
highlight
excit
applic
cnt
boost
research
effort
unfortun
otherwis
scatter
literatur
make
read
noncoher
nonhomogen
review
post
screen
current
scenario
cnt
one
forefront
divers
field
medicin
continu
explor
research
scientist
academician
develop
new
safe
effect
nanomedicin
cnt
promis
quasi
onedimension
nanomateri
well
order
flat
network
fuse
benzen
ring
hollow
graphit
cylindr
tubular
structur
consist
hexagon
arrang
sp
hybrid
carbon
atom
cnt
mainli
classifi
four
type
base
upon
structur
diamet
includ
singl
doubl
tripl
multiwal
carbon
nanotub
length
tube
extend
depend
type
product
method
cnt
one
attract
tool
nanotechnolog
surfac
engin
carbon
nanotub
fcnt
emerg
new
famili
carbon
nanovector
enabl
numer
biomed
applic
function
play
pivot
role
design
cntsbase
nanomateri
render
biocompat
less
toxic
increas
dispers
comparison
pristin
cnt
methodolog
function
cnt
classifi
broadli
two
categori
coval
attach
activ
biochem
moieti
chemic
reaction
onto
cnt
skeleton
b
noncoval
adsorpt
wrap
differ
function
molecul
variou
type
nanocomposit
summar
fig
studi
cellular
uptak
mechan
surfac
engin
cnt
intens
address
last
two
decad
lacerda
et
al
demonstr
surfac
engin
cnt
propens
enter
cell
via
energydepend
endosomallymedi
cellular
intern
approach
direct
cytoplasm
transloc
insert
passiv
diffus
noninvas
manner
tini
nanoneedl
mechan
fcnt
easili
cross
blood
brain
barrier
bbb
without
requir
extern
transport
devic
owe
nanodimens
tini
nanoneedl
tubular
structur
morpholog
fig
main
pathway
specul
scientist
cellular
uptak
fcnt
phagocytosi
ii
cnt
pierc
membran
passiv
diffus
iii
caveolaemedi
endocytosi
iv
clathrinmedi
endocytosi
v
caveolaeclathrin
mediat
endocytosi
intracellular
uptak
mechan
cnt
crucial
control
uptak
devis
new
strategi
field
novel
drug
deliveri
report
shown
nanotub
may
enter
cell
rapidli
free
traffick
cytoplasm
first
hour
intern
penetr
surfac
engin
cnt
phagocyt
nonphagocyt
cell
mediat
three
altern
pathway
via
membran
wrap
individu
tube
ii
via
direct
membran
transloc
individu
nanotub
iii
bundl
within
vesicular
compart
fig
excit
fact
intracellular
traffick
cnt
open
new
door
develop
promis
deliveri
system
therapeut
diagnost
agent
potenti
surfac
engin
cnt
possibl
biomed
applic
discuss
variou
cnt
conjug
employ
bioactiv
deliveri
shown
fig
transderm
drug
deliveri
system
tdd
repres
convinc
well
promis
altern
oral
inject
deliveri
drug
recent
cnt
investig
tdd
due
tini
nanoneedl
shape
structur
superior
adsorpt
capac
im
cowork
prepar
electrosensit
tdd
cnt
use
electrospin
method
control
drug
releas
polyethylen
oxid
pentaerythritol
triacryl
polym
tdd
cnt
facilit
electrosensitivetransderm
drug
deliveri
advantag
cnt
tdd
includ
high
load
effici
enhanc
transderm
penetr
drug
applic
small
electr
bia
creat
programm
drug
deliveri
system
futur
explor
fcnt
tdd
present
feasibl
solut
limit
current
smoke
cessat
opioid
withdraw
symptom
treatment
sever
approach
exploit
develop
safe
biocompat
comfort
nanovehicl
control
ophthalm
drug
deliveri
enhanc
patient
complianc
reduc
toxic
ophthalm
drug
short
resid
time
min
appli
therapi
may
penetr
cornea
enter
intraocular
tissu
cntsbase
ocular
drug
deliveri
found
enhanc
bioavail
ophthalm
medic
overcom
limit
tradit
ophthalm
drug
deliveri
method
cnt
could
also
use
ocular
target
differ
therapeut
agent
differ
ocular
site
unfortun
report
avail
area
applic
kajal
also
known
kohl
surma
common
practic
indian
famili
kajal
claim
prevent
treatment
variou
eye
diseas
blephar
cataract
conjunct
etc
also
said
ward
evil
eye
cosmet
applic
cnt
well
document
variou
literatur
surfac
engin
cnt
base
deliveri
system
explor
new
platform
repair
damag
cn
tissuecel
field
neurosci
cnt
claim
abl
cross
blood
brain
barrier
bbb
differ
target
mechan
act
safe
effect
target
drug
deliveri
system
sinc
last
onedecad
research
continu
explor
assess
cnt
substrat
neuron
tissu
growth
regener
applic
neurosci
research
cnt
numer
salient
featur
simpl
inert
molecular
tubular
nanoneedl
structur
poros
benefici
neural
interfac
traffick
cell
sens
microenviron
deliveri
transfect
agent
scaffold
incorpor
within
host
bodi
provid
support
adhes
prolifer
migrat
cell
ren
cowork
develop
dual
target
deliveri
system
base
oxid
pegyl
mwcnt
modifi
target
ligand
lowdens
lipoprotein
receptor
relatedprotein
lrp
receptor
load
doxorubicin
dox
systemat
evalu
vitro
vivo
antiglioma
effect
cytotox
median
surviv
time
mst
intracrani
glioma
bear
balbc
mice
combin
omwcntspeg
target
ligand
claim
play
role
activ
dualtarget
combin
omwcntspeg
constitut
ideal
dualtarget
drug
deliveri
brain
glioma
photodynam
therapi
pdt
effect
altern
noninvas
nontox
therapi
use
oncolog
till
date
number
report
avail
applic
surfac
engin
cnt
pdt
photosensit
acid
load
pamam
dendrim
modifi
mwcnt
dmnt
show
good
biocompat
signific
increas
accumul
tumor
cell
lead
potenti
photodynam
antitumor
effect
chitosan
wrap
photosensit
load
swcnt
reveal
high
cellular
uptak
high
anticanc
effect
low
toxic
hela
cancer
cell
free
cnt
hold
promis
phototherm
therapi
ptt
due
extraordinari
photontotherm
energi
convers
effici
high
absorpt
near
infrar
nir
light
swcnt
abil
absorb
nm
nir
radiat
convert
heat
kill
cancer
cell
moon
cowork
demonstr
phototherm
effect
pegyl
swcnt
upon
nir
irradi
kb
tumor
bear
nude
mice
observ
suffici
high
thermal
energi
gener
optic
excit
pegswcnt
destroy
tumor
noninvas
manner
mice
treat
pegswcnt
nir
irradi
cnt
conjug
employ
bioactiv
deliveri
wwwdrugdiscoverytodaycom
review
post
screen
folic
acid
fa
chitosan
chi
algin
alg
swcnt
hela
cell
line
doxorubicin
pp
stack
fluoresc
cell
viabil
cell
uptak
studi
cnt
complex
found
select
effect
free
dox
due
target
base
fa
releas
dox
lysosom
ph
mabbsa
adsorbedswcnt
wpdr
colon
cancer
cell
line
doxorubicin
pp
stack
electron
microscopi
sem
hrtem
raman
spectroscopi
uptak
studi
reveal
deliveri
effici
cell
could
take
swcnt
complex
diaminotriethylen
glycolmwcnt
hcpt
pp
stack
vitro
singl
photon
emiss
comput
tomographi
spect
show
complet
erad
solid
malign
tumor
devoid
toxic
abnorm
behavior
day
post
treatment
issu
concern
residu
swcnt
accumul
insid
bodi
treatment
resolv
nanotub
excret
mice
bodi
month
biliari
urinari
pathway
biodistribut
studi
hashida
cowork
report
phototherm
ablat
activ
novel
swcntspeptid
composit
design
peptid
repeat
structur
h
lysphelysala
oh
kfka
tumor
cell
obtain
result
suggest
remark
suppress
tumor
growth
compar
swcnt
kfka
inject
alon
nir
irradi
alon
current
viral
vector
system
base
gene
deliveri
wide
use
achiev
high
effici
gene
express
concern
safeti
viral
vector
immunogen
oncogen
may
respons
inflamm
gene
therapi
may
suffer
rapid
degrad
exogen
nucleic
acid
nowaday
effect
multipl
nonvir
deliveri
system
like
polymer
nanoparticl
liposom
cell
penetr
peptid
cation
lipid
dendrim
fcnt
employ
effici
deliv
nucleic
acid
includ
sirna
reduc
immunogen
effici
gene
express
mediat
nanovector
lower
compar
viral
vector
provid
advantag
easi
upscal
flexibl
reduc
immunogen
applic
cnt
new
vector
deliveri
nucleic
acid
anoth
area
research
develop
could
offer
sever
advantag
nucleic
acid
sirna
gene
protein
deliveri
owe
thin
long
architectur
offer
larg
surfac
area
sirna
bound
deliv
target
site
cnt
may
protect
capac
stabil
lead
effici
cellular
transfect
prevent
lysosom
degrad
encapsul
nucleic
acid
kawaguchi
cowork
synthes
dnafunction
swcnt
improv
dispers
compar
acid
treat
swcnt
bind
ratio
acidtr
swcnt
dna
calcul
dnaswcnt
phosphor
content
dnaswcnt
context
enhanc
gene
deliveri
sanz
cowork
first
develop
demonstr
enhanc
gene
deliveri
use
lysosomotrop
antimalari
drug
chloroquin
load
polyethyleneimin
pei
coat
dwcnt
enhanc
cell
transfect
effici
infecti
diseas
tuberculosi
leishmaniasi
sever
acut
respiratori
syndrom
sar
flu
swine
bird
avian
anthrax
infect
indic
infecti
diseas
emerg
critic
public
health
issu
global
concern
surfac
engin
cnt
use
treatment
infecti
diseas
due
abil
easili
conjug
drug
like
amphotericin
b
amb
dapson
leishmaniasi
microbi
diseas
macrophag
cell
reticuloendotheli
system
re
serv
host
well
replic
site
parasit
conjug
amphotericin
b
amb
fcnt
modifi
properti
term
toxic
antimycot
effici
drug
discoveri
today
volum
number
june
cell
sorter
analysi
found
effect
deliveri
vehicl
control
releas
enhanc
cytotox
render
apoptosi
hela
cell
glmwcntsdox
wu
cowork
explor
toxic
antifung
activ
amb
load
cnt
ambcnt
function
fluorescein
isothiocyn
fitc
effici
nuclear
local
human
jurkat
lymphoma
cell
observ
ambcnt
could
easili
taken
mammalian
cell
preclud
specif
toxic
effect
preserv
antifung
activ
cnt
surfac
engin
mannos
show
promis
target
deliveri
amb
macrophag
cell
cancer
one
lead
caus
death
worldwid
case
chemotherapi
destroy
cancer
cell
alongwith
normal
healthi
cell
seriou
side
effect
henc
strategi
base
nanotechnolog
explor
safe
effect
strategi
achiev
select
uptak
chemotherapeut
agent
target
cancer
cell
signific
decreas
toxic
preferenti
kill
cancer
cell
achiev
dual
target
nanocarri
combin
mwcnt
iron
oxid
magnet
nanoparticl
mn
conjug
fa
antineoplast
agent
dox
jain
cowork
observ
tumor
target
deliveri
dox
reduc
toxic
dox
load
dexamethason
mesyl
anchor
mwcnt
lung
epitheli
cancer
cell
cnt
surfac
engin
folic
acid
dalpha
tocopheryl
polyethylen
glycol
succin
tpg
show
tumor
target
deliveri
dox
improv
cytotox
toward
cancer
cell
enhanc
cellular
uptak
specul
mediat
endocytosi
tini
nanoneedl
mechan
fig
present
differ
conjug
base
cnt
employ
deliveri
anticanc
bioactiv
vari
pristin
cnt
drug
load
cnt
aforesaid
account
may
conclud
surfac
engin
cnt
could
promis
potenti
cancer
therapi
report
show
cnt
may
emerg
promis
nanocarri
target
macrophag
owe
except
physicochem
characterist
amb
conjug
cnt
show
improv
antileishmani
activ
compar
free
amb
macrophag
cell
later
amb
load
mannos
conjug
cnt
show
effici
macrophag
target
macrophag
cell
line
significantli
reduc
toxic
toward
rbc
kidney
cell
show
consider
reduct
nephroand
hemolytictox
major
constraint
clinic
use
amb
brief
summari
variou
bioactiv
deliv
surfac
engin
cnt
shown
tabl
cnt
alon
well
combin
nanocarri
like
dendrim
nanoparticl
quantum
dot
emerg
promis
novel
drug
deliveri
diagnost
nanovector
tool
minim
toxic
immunogen
delogu
cowork
assess
echogen
properti
nanotub
vitro
found
ultrasound
signal
fmwcnt
higher
pristin
mwcnt
graphen
oxid
fswcnt
author
found
mwcnt
highli
echogen
liver
heart
examin
pig
experiment
anim
model
thu
nanotub
could
show
enorm
potenti
ultrasound
contrast
agent
theragnost
moieti
combin
diagnost
therapeut
modal
smartintellig
surfac
engin
carbon
nanotub
still
controversi
biodegradablenonbiodegrad
natur
previou
literatur
suggest
nonbiodegrad
natur
cnt
excret
biliari
pathway
especi
via
urin
fece
howev
investig
observ
cnt
degrad
specif
environ
via
natur
enzymat
catalysi
natur
horseradish
peroxidas
hrp
low
concentr
h
approxim
mm
week
presenc
human
neutrophil
enzym
myeloperoxidas
importantli
biodegrad
nanotub
produc
inflammatori
respons
aspir
lung
mice
bianco
cowork
investig
biodegrad
swcnt
mwcnt
differ
condit
conclud
oxid
mwcnt
highli
degrad
natur
compar
swcnt
recent
literatur
report
support
biodegrad
natur
cnt
otherwis
previous
cnt
consid
nonbiodegrad
excret
examin
electron
microscop
studi
addit
biocompat
nanotub
could
prepar
via
conjug
phospholipid
pl
polyethylen
glycol
peg
chain
may
promis
altern
candid
biomed
applic
toxic
associ
cnt
yet
unclear
sever
research
studi
demonstr
toxic
pristin
cnt
could
fortun
minim
via
surfac
engin
render
biocompat
nonimmunogen
specif
structur
properti
cnt
like
needleshap
long
thin
biopersist
natur
insolubl
may
produc
advers
pulmonari
effect
potenti
risk
could
avoid
use
surfac
engin
cnt
howev
till
date
cnt
ecotoxicolog
data
limit
controversi
also
lack
reliabl
inform
exposur
per
occup
health
safeti
regul
contrast
ecotox
point
view
surfac
cnt
often
modifi
differ
chemic
reaction
graft
graft
make
cnt
biocompat
better
stabil
addit
signific
need
research
develop
field
analyt
detect
method
strict
norm
regul
need
develop
new
drug
product
safe
effect
econom
gener
regard
safe
gra
promin
cnt
potenti
novel
carrier
bioactiv
deliveri
make
promis
candid
develop
new
pharmaceut
product
clinic
relev
clinic
use
cnt
base
product
pharmacolog
toxicolog
paramet
must
prove
safe
effect
surfac
cnt
could
easili
engin
target
imag
agent
peptid
protein
sirna
nucleic
acid
antibodi
chemotherapeut
drug
aforement
pharmaceut
biomed
applic
surfac
engin
cnt
consid
promis
nanomateri
use
mani
biomed
applic
includ
biocompat
modul
deliveri
bioactiv
conclus
realiz
full
potenti
cnt
import
gener
data
safeti
efficaci
feasibl
although
scientist
optimist
possibl
applic
cnt
yet
learn
lesson
past
like
thalidomid
tragedi
safeti
efficaci
cntscnt
base
productsdevic
etc
must
establish
beyond
doubt
wit
emerg
sever
materialsdevicesproduct
could
make
way
market
research
let
keep
finger
cross
wait
conclus
proof
regard
possibl
applic
cnt
particularli
biomed
arena
conclus
drawn
either
hast
without
conclus
evid
safeti
